Collagen-targeted MRI contrast agent for molecular Imaging of fibrosis

被引:198
作者
Caravan, Peter
Das, Biplab
Dumas, Stephane
Epstein, Frederick H.
Helm, Patrick A.
Jacques, Vincent
Koerner, Steffi
Kolodziej, Andrew
Shen, Luhua
Sun, Wei-Chuan
Zhang, Zhaoda
机构
[1] EPIX Pharmaceut Inc, Lexington, MA 02421 USA
[2] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA
[3] Univ Virginia, Dept Radiol, Charlottesville, VA 22908 USA
关键词
D O I
10.1002/anie.200700700
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
(Figure Presented) A cyclic peptide specific for type I collagen is derivatized with three {Cd(dtpa)} moieties to create a molecular MRI contrast agent for fibrosis imaging. In a mouse model of myocardial infarction (heart attack), collagen levels are elevated in the infarct zone. MRI after injection of the contrast agent selectively enhances and delineates the infarct zone (see preinjection and postinjection images); dtpa = diethylenetriaminepentaacetate. © 2007 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:8171 / 8173
页数:3
相关论文
共 20 条
[1]   Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease [J].
Brilla, CG ;
Funck, RC ;
Rupp, H .
CIRCULATION, 2000, 102 (12) :1388-1393
[2]   Strategies for increasing the sensitivity of gadolinium based MRI contrast agents [J].
Caravan, Peter .
CHEMICAL SOCIETY REVIEWS, 2006, 35 (06) :512-523
[3]   MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions [J].
Epstein, FH ;
Yang, ZQ ;
Gilson, WD ;
Berr, SS ;
Kramer, CM ;
French, BA .
MAGNETIC RESONANCE IN MEDICINE, 2002, 48 (02) :399-403
[4]   Reversal of hepatic fibrosis - Fact or fantasy? [J].
Friedman, SL ;
Bansal, MB .
HEPATOLOGY, 2006, 43 (02) :S82-S88
[5]   Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis [J].
Gharaee-Kermani, M ;
Phan, SH .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (30) :3943-3971
[6]   Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models [J].
Jugdutt, BI ;
Joljart, MJ ;
Khan, MI .
CIRCULATION, 1996, 94 (01) :94-101
[7]   Viability assessment by delayed enhancement cardiovascular magnetic resonance - Will low-dose dobutamine dull the shine? [J].
Kim, RJ ;
Manning, WJ .
CIRCULATION, 2004, 109 (21) :2476-2479
[8]   Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI [J].
Morawski, AM ;
Winter, PM ;
Crowder, KC ;
Caruthers, SD ;
Fuhrhop, RW ;
Scott, MJ ;
Robertson, JD ;
Abendschein, DR ;
Lanza, GM ;
Wickline, SA .
MAGNETIC RESONANCE IN MEDICINE, 2004, 51 (03) :480-486
[9]   Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging [J].
Mulder, WJM ;
Strijkers, GJ ;
van Tilborg, GAF ;
Griffioen, AW ;
Nicolay, K .
NMR IN BIOMEDICINE, 2006, 19 (01) :142-164
[10]  
NEUMAN RE, 1950, J BIOL CHEM, V186, P546